Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research
2015
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2012 Standout
Clinician’s Guide to Prevention and Treatment of Osteoporosis
2014 Standout
UK clinical guideline for the prevention and treatment of osteoporosis
2017
The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis
1988 Standout
Glutamate receptor ion channels
2005 Standout
Child abuse: Adolescent records vs. adult recall
1990 Standout
Health benefits of physical activity: the evidence
2006 Standout
Treatment with intermittent calcitriol and calcium reduces bone loss after renal transplantation
2004
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
2010
Osteoporosis
2019 Standout
Bisphosphonate Therapy for Osteoporosis: Benefits, Risks, and Drug Holiday
2012
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
2009 Standout
Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis
2007
Physical activity and predisposition for hip fractures: A review
1997
Alzheimer's disease
2011 Standout
The contribution of the study of neurodegenerative disorders to the understanding of human memory
2004
Urinary dysfunction in Parkinson's disease: A review
2008
The Subtype-Selective Nicotinic Acetylcholine Receptor Agonist SIB-1553A Improves Both Attention and Memory Components of a Spatial Working Memory Task in Chronic Low Dose 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Treated Monkeys
2003
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Fracture rate associated with quality metric-based anti-osteoporosis treatment in glucocorticoid-induced osteoporosis
2015
Overdependence on degraded gist memory in Alzheimer's disease.
2006 Standout
Osteoporosis: now and the future
2011 Standout
Parkinson's disease
2009 Standout
Glucocorticoid-induced Osteoporosis
2000
The impact of deep brain stimulation on executive function in Parkinson's disease
2000
Skeletal remodeling in health and disease
2007 Standout
Osteoporosis in men: Epidemiology, diagnosis, prevention, and treatment
2004
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
Giant Cell Arteritis
1994
Five year study of etidronate and/or calcium as prevention and treatment for osteoporosis and fractures in patients with asthma receiving long term oral and/or inhaled glucocorticoids
2004
Insights into the ageing mind: a view from cognitive neuroscience
2004 Standout
Mechanisms involved in the side effects of glucocorticoids
2002 Standout
A Review of the Cognitive and Behavioral Sequelae of Parkinson's Disease: Relationship to Frontostriatal Circuitry
2003
A neuropsychological theory of positive affect and its influence on cognition.
1999 Standout
Prevention and treatment of osteoporosis in inflammatory bowel disease
2006
Parkinson's disease
2015 Standout
Pathophysiological distortions in time perception and timed performance
2011 Standout
Risedronate, an effective treatment for glucocorticoid-induced bone loss in CKD patients with or without concomitant active vitamin D (PRIUS-CKD)
2006
Diagnosis and Complications of Cushing’s Syndrome: A Consensus Statement
2003 Standout
Biochemical Markers of Bone Turnover in the Clinical Development of Drugs for Osteoporosis and Metastatic Bone Disease
2006
Five-Year Follow-up of Bilateral Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease
2003 Standout
Chronic arthritis leads to disturbances in the bone collagen network
2010 StandoutNobel
Treatment interventions for Parkinson's disease: an evidence based assessment
2002
The neural basis of human error processing: Reinforcement learning, dopamine, and the error-related negativity.
2002 Standout
Sensory and cognitive functions of the basal ganglia
1997
Single Intranasal Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine in C57BL/6 Mice Models Early Preclinical Phase of Parkinson’s Disease
2009
Teriparatide or Alendronate in Glucocorticoid-Induced Osteoporosis
2007
The interplay of cholinergic function, attention, and falls in Parkinson's disease
2011
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
Severe Adverse Cutaneous Reactions to Drugs
1994 Standout
Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial
2009
Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease
2004 Standout
Non-motor features of Parkinson disease
2017 Standout
American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis
2010
Polymyalgia Rheumatica and Giant-Cell Arteritis
2002 Standout
Short‐term effect of a single levodopa dose on micturition disturbance in Parkinson's disease patients with the wearing‐off phenomenon
2003
Oral bisphosphonates reduce the risk of clinical fractures in glucocorticoid-induced osteoporosis in clinical practice
2012
Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline
2007
Medication impairs probabilistic classification learning in Parkinson's disease
2009
Frailty in elderly people
2013 Standout
Cognitive Impairment in Parkinson’s Disease: The Dual Syndrome Hypothesis
2012
Prevention of falls and consequent injuries in elderly people
2005 Standout
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Dopamine, learning and motivation
2004 Standout
Immunological aspects of cryoprecipitates from the sera of chronic HBsAg carriers.
1979
AUTOANTIBODIES AGAINST NEUTROPHILS AND MONOCYTES: TOOL FOR DIAGNOSIS AND MARKER OF DISEASE ACTIVITY IN WEGENER'S GRANULOMATOSIS
1985 Standout
Disorders Associated With Acute Rapid and Severe Bone Loss
2003
Incidental and intentional recall in Parkinson's disease: An account based on diminished attentional resources
1993
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Management of Parkinson's disease: An evidence-based review
2002
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
The Spectrum of Vasculitis
1978 Standout
The Tromsø Study: Physical Activity and the Incidence of Fractures in a Middle-Aged Population
1998
Prevalence and determinants of osteoporosis drug prescription among patients with high exposure to glucocorticoid drugs.
2001
COGNITIVE NEUROSCIENCE OF HUMAN MEMORY
1998
Polymyalgia Rheumatica
1982
Incidence and Economic Burden of Osteoporosis-Related Fractures in the United States, 2005–2025
2006 Standout
Mechanisms of Estrogen Action
2001 Standout
Systematic Review: Comparative Effectiveness of Treatments to Prevent Fractures in Men and Women with Low Bone Density or Osteoporosis
2008
Parathyroid Hormone and Teriparatide for the Treatment of Osteoporosis: A Review of the Evidence and Suggested Guidelines for Its Use
2005
Low dose glucocorticoids in early rheumatoid arthritis.
2004
Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks
1997 Standout
Neuropsychological changes between “off” and “on” STN or GPi stimulation in Parkinson’s disease
2000
Clinical and pathologic studies of synovitis in polymyalgia rheumatica
1984
Wegener's Granulomatosis: Prospective Clinical and Therapeutic Experience With 85 Patients for 21 Years
1983 Standout
D1- Versus D2-Receptor Modulation of Visuospatial Working Memory in Humans
1998
The Nature of Recollection and Familiarity: A Review of 30 Years of Research
2002 Standout
The selective oestrogen receptor modulation: evolution and clinical applications
1999
Individual differences in rates of change in cognitive abilities of older persons.
2002 Standout
Neuropathology of older persons without cognitive impairment from two community-based studies
2006 Standout
Serum Levels of Immunoglobulin and Complement in Giant-Cell Arteritis
1976
Safety and Efficacy of Risedronate in Patients With Age-Related Reduced Renal Function as Estimated by the Cockcroft and Gault Method: A Pooled Analysis of Nine Clinical Trials
2005
Mixed cryoglobulinemia: Clinical aspects and long-term follow-up of 40 patients
1980 Standout
Osteoporosis in men.
2003
Works of S. M. Doherty being referenced
The technical and logistical feasibility of population densitometry using DXA and directed HRT intervention: A 2-year prospective study
1996
Effects of Risedronate Treatment on Bone Density and Vertebral Fracture in Patients on Corticosteroid Therapy
2000
DIFFERENT EFFECTS OF DOPAMINERGIC AND ANTICHOLINERGIC THERAPIES ON COGNITIVE AND MOTOR FUNCTION IN PARKINSON'S DISEASE
1992
The effect of prior bisphosphonate therapy on the subsequent therapeutic effects of strontium ranelate over 2 years
2011
HEPATITIS-B ANTIBODY IN POLYMYALGIA RHEUMATICA
1975
Polymyalgia rheumatica. Abrupt and gradual withdrawal of prednisolone treatment, clinical and laboratory observations.
1977